Merck-Moffitt Personalized Medicine Partnership Builds out Information and Data Integration Pipeline

"Now, as soon as a patient is enrolled in MCC's Total Cancer Care program, and biosamples are collected for profiling at Merck, all available data are transmitted to Merck's clinical repository for subsequent publication from Merck's [clinical data repository] to researchers," a Merck official said.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.